Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial (Q48602872)

13 February 2018

title

Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309204

11 September 2022

Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

30 November 2023

main subject

phase II clinical trial

0 references

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

30 November 2023

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

30 November 2023

author name string

L. W. Brady

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309204

11 September 2022

C. Miyamoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309204

11 September 2022

D. V. Woo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309204

11 September 2022

M. Rackover

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309204

11 September 2022

J. Emrich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309204

11 September 2022

H. Bender

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309204

11 September 2022

S. Dadparvar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309204

11 September 2022

Z. Steplewski

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309204

11 September 2022

H. Koprowski

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309204

11 September 2022

P. Black

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309204

11 September 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

13 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:036030169291009C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

https://api.elsevier.com/content/article/PII:036030169291009C?httpAccept=text/plain

30 November 2023

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

International Journal of Radiation Oncology Biology Physics

30 November 2023

published in

1 reference

13 February 2018

volume

22

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

225-230

1 reference

13 February 2018

Studies on high grade cerebral gliomas

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Iodine-125 cytotoxicity: implications for therapy and estimation of radiation risk

30 November 2023

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

The Radiotoxicity of Iodine-125 in Mammalian Cells: I. Effects on the Survival Curve of Radioiodine Incorporated into DNA

30 November 2023

6

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

The radiotoxicity of iodine-125 in mammalian cells II. A comparative study on cell survival and cytogenetic responses to 125IUdR, 131TUdR, and 3HTdR

30 November 2023

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

30 November 2023

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen.

30 November 2023

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

30 November 2023

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Radioactive labeling of antibody: a simple and efficient method

30 November 2023

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Radiotoxicity of Intranuclear Tritium, 125 Iodine and 131 Iodine

30 November 2023

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Primary Intracranial Neoplasms

30 November 2023

15

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

30 November 2023

18

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide

30 November 2023

20

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.

30 November 2023

21

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Influence of radiation on the blood-brain barrier and optimum time of chemotherapy.

30 November 2023

22

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors

30 November 2023

23

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

High dose radiation therapy in the treatment of malignant gliomas: Final Report

30 November 2023

24

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.

30 November 2023

25

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation.

30 November 2023

26

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91009-C

30 November 2023

Identifiers

1 reference

13 February 2018

1 reference

13 February 2018